Singh said the online outpatient platform will ensure widespread access to quality health services in remote areas besides reducing the load on the hospitals.
The second and much more lethal COVID-19 wave, which swept through India in April and early May, is believed to be abating as the number of people getting infected or...
Rajnath launches telemedicine portal for military personnel
Updated:
Updated:
Last tranche of medical aid arrives from South Korea.
Share Article
AAA
Defence Minister Shri Rajnath Singh launches a ‘Services e-Health Assistance & Tele-consultation’ (SeHAT) OPD portal through video conferencing, in Delhi on May 27, 2021.
| Photo Credit:
PTI
Last tranche of medical aid arrives from South Korea.
Defence Minister Rajnath Singh on Thursday launched the Services e-Health Assistance and Tele-consultation (SeHAT) portal, which will provide tele-medicine services to serving military personnel, veterans and their families.
“This is the final version of the SeHAT OPD portal with advanced safety features. The trial version was made functional in August 2020. More than 6,500 medical consultations have already been carried on the beta version by service doctors,” a Defence Ministry statement said.
Defence Minister Rajnath Singh on Thursday launched an online medical consultation service for the armed forces personnel and the veterans to ensure hassle-free health services for them.
Rajnath Singh launches online OPD portal for armed forces personnel, ex-servicemen freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
In a congratulatory letter to Dr. Purkayastha on Wednesday, Chief Minister Sarma, said, "Assam is really proud of you for your role in several scientific forums of the country. Your association with DRDO and your role as an active member of the team that developed anti-COVID drug 2-DG is your sacred privilege."
Yeafesh inaugurates uplift projects in Rajshahi
203
RAJSHAHI, May 26, 2021 (BSS)- Science and Technology Minister Architect Yeafesh Osman today spent a busy day by inaugurating and visiting different development projects in Rajshahi city.
The Minister formally inaugurated the newly constructed building of the Institute of Nuclear Medicine and Allied Sciences (INMAS) in the compound of Rajshahi Medical College and Hospital.
The building has been constructed at a cost of around TK 20 crore.
INMAS provides not only nuclear medicine service to the patients but also plays a vital role for human resource development in this field. This gives a new dimension to the endeavor to represent the institute as a “Centre of Excellence” in the field of nuclear medicine services in Bangladesh.
Assam Chief Minister Himanta Biswa Sarma congratulated Dr Jubilee Purkayastha, a scientist with the Institute of Nuclear Medicine and Allied Sciences, for her outstanding contributions in the development of an anti-Covid drug.
Express News Service
PUDUCHERRY: Puducherry Lt Governor Dr. Tamilisai Soundararajan got some sample ‘2-DG’ drugs, the indigenously developed anti-Covid-19 drug, 2-deoxy-D-glucose or ‘2-DG’ from Telangana to Puducherry on Tuesday
The 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL).
The drug is effective and Covid patients improved symptomatically and became free from supplemental oxygen dependence, said Dr. Tamilisai Soundararajan, who herself is a medico.
The medicine which is given for 10 days, provided an early relief from oxygen dependence gradually after four days. Stating that she has held discussions through video conferencing with the producers and requested them to provide the medicine to Puducherry when it is made available in all states in a week or two.
'DRDO's drug was effective on brain cancer patients, can't say about Covid-19'
DRDO’s drug was first used in a human clinical study on brain tumour patients by Dr A K Banerji at AIIMS, Delhi, along with Dr Viney Jain, former director of INMAS LAB.
Share Via Email
| A+A A-
Dr AK Banerji who served at AIIMS' neurosurgery department for 30 years, said that the drug was reasonably effective on cancer.
Express News Service
NEW DELHI: Oral anti-viral drug 2-deoxy-D-glucose (2-DG), developed by the DRDO and being touted as a potential game-changer in the battle against Covid-19, was first used in a human clinical study on brain tumour patients by Dr A K Banerji at AIIMS, Delhi, along with Dr Viney Jain, former director of INMAS LAB (DRDO).